Pancreatic Cancer Research

ResearcherUniversity of ArizonaActive in the last 2 years

Christopher Cartmell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8722-9187; OpenAlex author ID A5049163520. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neo.2026.101379↗
  2. Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. Last author DOI 10.3390/md24060201↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nam Y Lee · 2 shared papers, 2026 · strength 0.53
  2. Nathan A. Ellis · 1 shared paper, 2026 · strength 0.28
  3. Hannah R. Ortiz · 1 shared paper, 2026 · strength 0.28
  4. Caleb A. Seekins · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.